Publicaciones en colaboración con investigadores/as de Hospital Universitario de Valladolid (135)

2024

  1. Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: results of a Delphi study

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 337-346

  2. FIB-4 score as a predictor of COVID-19-related severity in hospitalized patients

    Revista Espanola de Enfermedades Digestivas, Vol. 116, Núm. 9, pp. 465-471

  3. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression

    United European Gastroenterology Journal, Vol. 12, Núm. 8, pp. 1056-1068

  4. Letter to the Editor: Serum Identification of At-Risk MASH: The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)

    Hepatology

  5. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia

  6. Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease

    Gut, Vol. 73, Núm. 5, pp. 825-834

  7. Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)

    Hepatology, Vol. 79, Núm. 1, pp. 135-148

  8. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

    Journal of Gastroenterology, Vol. 59, Núm. 7, pp. 586-597

2023

  1. AEEH «Consensus about detection and referral of hidden prevalent liver diseases»

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 3, pp. 236-247

  2. Association of the leptin receptor rs1805134 polymorphism with obesity parameters, dietary intakes, and metabolic syndrome in Caucasian obese subjects

    Nutricion Hospitalaria, Vol. 40, Núm. 1, pp. 35-40

  3. Dietary intervention with 2 different fat profiles; role of the rs822393 variant in metabolic parameter changes

    Nutricion Hospitalaria, Vol. 40, Núm. 1, pp. 49-58

  4. Liver investigation: Testing marker utility in steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol

    Contemporary Clinical Trials, Vol. 134

  5. Role of resistin (rs7139228) gene polymorphism with metabolic response after a hypocaloric mediterranean diet

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 2, pp. 88-97

2022

  1. A Pilot Study of Gene Expression Analysis in Peripheral Blood Mononuclear Cells in Response to a Hypocaloric Mediterranean Diet

    Disease markers, Vol. 2022, pp. 3706753

  2. A Randomized Trial with Two Hypocaloric Diets with Different Lipid Profiles and Effects on Serum Omentin-1 Levels in Obese Subjects

    Disease markers, Vol. 2022, pp. 6777283

  3. Association of the APOA-5 Genetic Variant rs662799 with Metabolic Changes after an Intervention for 9 Months with a Low-Calorie Diet with a Mediterranean Profile

    Nutrients, Vol. 14, Núm. 12

  4. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach?

    Gut, Vol. 71, Núm. 2, pp. 382-390

  5. Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality

    Critical Care, Vol. 26, Núm. 1

  6. Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles

    Hepatology, Vol. 76, Núm. 4, pp. 1121-1134

  7. Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology

    Liver International, Vol. 42, Núm. 8, pp. 1783-1792